Aggressive progressive pleuroparenchymal fibroelastosis developed long after allogenic hematopoietic stem cell transplantation

Key Clinical Message The typical pleuroparenchymal fibroelastosis (PPFE) after hematopoietic stem cell transplantation (HSCT) is characterized by late‐onset progressive pulmonary complication within 5 years. PPFE shows a poor prognosis without definitive standard care other than lung transplantation...

Full description

Bibliographic Details
Main Authors: Osamu Imataki, Makiko Uemura
Format: Article
Language:English
Published: Wiley 2024-01-01
Series:Clinical Case Reports
Subjects:
Online Access:https://doi.org/10.1002/ccr3.8415
_version_ 1797335004646211584
author Osamu Imataki
Makiko Uemura
author_facet Osamu Imataki
Makiko Uemura
author_sort Osamu Imataki
collection DOAJ
description Key Clinical Message The typical pleuroparenchymal fibroelastosis (PPFE) after hematopoietic stem cell transplantation (HSCT) is characterized by late‐onset progressive pulmonary complication within 5 years. PPFE shows a poor prognosis without definitive standard care other than lung transplantation. Our case indicated an over 20 years late‐onset and aggressively exacerbating PPFE.
first_indexed 2024-03-08T08:30:33Z
format Article
id doaj.art-80a118e5389c44f2b38305d78509380c
institution Directory Open Access Journal
issn 2050-0904
language English
last_indexed 2024-03-08T08:30:33Z
publishDate 2024-01-01
publisher Wiley
record_format Article
series Clinical Case Reports
spelling doaj.art-80a118e5389c44f2b38305d78509380c2024-02-02T03:36:31ZengWileyClinical Case Reports2050-09042024-01-01121n/an/a10.1002/ccr3.8415Aggressive progressive pleuroparenchymal fibroelastosis developed long after allogenic hematopoietic stem cell transplantationOsamu Imataki0Makiko Uemura1Division of Hematology, Department of Internal Medicine, Faculty of Medicine Kagawa University Takamatsu JapanDivision of Hematology, Department of Internal Medicine, Faculty of Medicine Kagawa University Takamatsu JapanKey Clinical Message The typical pleuroparenchymal fibroelastosis (PPFE) after hematopoietic stem cell transplantation (HSCT) is characterized by late‐onset progressive pulmonary complication within 5 years. PPFE shows a poor prognosis without definitive standard care other than lung transplantation. Our case indicated an over 20 years late‐onset and aggressively exacerbating PPFE.https://doi.org/10.1002/ccr3.8415hematopoietic stem cell transplantation (HSCT)late‐onset noninfectious pulmonary complication (LONIPC)pleuroparenchymal fibroelastosis (PPFE)
spellingShingle Osamu Imataki
Makiko Uemura
Aggressive progressive pleuroparenchymal fibroelastosis developed long after allogenic hematopoietic stem cell transplantation
Clinical Case Reports
hematopoietic stem cell transplantation (HSCT)
late‐onset noninfectious pulmonary complication (LONIPC)
pleuroparenchymal fibroelastosis (PPFE)
title Aggressive progressive pleuroparenchymal fibroelastosis developed long after allogenic hematopoietic stem cell transplantation
title_full Aggressive progressive pleuroparenchymal fibroelastosis developed long after allogenic hematopoietic stem cell transplantation
title_fullStr Aggressive progressive pleuroparenchymal fibroelastosis developed long after allogenic hematopoietic stem cell transplantation
title_full_unstemmed Aggressive progressive pleuroparenchymal fibroelastosis developed long after allogenic hematopoietic stem cell transplantation
title_short Aggressive progressive pleuroparenchymal fibroelastosis developed long after allogenic hematopoietic stem cell transplantation
title_sort aggressive progressive pleuroparenchymal fibroelastosis developed long after allogenic hematopoietic stem cell transplantation
topic hematopoietic stem cell transplantation (HSCT)
late‐onset noninfectious pulmonary complication (LONIPC)
pleuroparenchymal fibroelastosis (PPFE)
url https://doi.org/10.1002/ccr3.8415
work_keys_str_mv AT osamuimataki aggressiveprogressivepleuroparenchymalfibroelastosisdevelopedlongafterallogenichematopoieticstemcelltransplantation
AT makikouemura aggressiveprogressivepleuroparenchymalfibroelastosisdevelopedlongafterallogenichematopoieticstemcelltransplantation